Larren E. Smith

Statistics

Publications

Citations

321

H-Index

Active since

1994

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

National Institutes of Health

University of Arizona

National Institute on Drug Abuse

Larren E. Smith is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in pharmacology, ligand binding, and opioid analgesics.

Publications per year

1994–1999

Publications

Probes for Narcotic Receptor Mediated Phenomena. 19. Synthesis of (+)-4-[(.alpha.R)-.alpha.-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): A Highly Selective, Nonpeptide .delta. Opioid Receptor Agonist

Silvia N. Calderon, Richard B. Rothman, Frank Porreca et al. · Journal of Medicinal Chemistry · 1994 · 217 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Probes for Narcotic Receptor Mediated Phenomena. 23. Synthesis, Opioid Receptor Binding, and Bioassay of the Highly Selective δ Agonist (+)-4-[(αR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and Related Novel Nonpeptide δ Opioid Receptor Ligands

Silvia N. Calderon, Kenner C. Rice, Richard B. Rothman et al. · Journal of Medicinal Chemistry · 1997 · 85 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Probes for Narcotic Receptor Mediated Phenomena. 26. Synthesis and Biological Evaluation of Diarylmethylpiperazines and Diarylmethylpiperidines as Novel, Nonpeptidic δ Opioid Receptor Ligands

Xiaoyan Zhang, Kenner C. Rice, Silvia N. Calderon et al. · Journal of Medicinal Chemistry · 1999 · 19 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

1–3 of 3